Search Results - "Shi, XB"

Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome by Bittner, Vera A., Szarek, Michael, Aylward, Philip E., Bhatt, Deepak L., Diaz, Rafael, Edelberg, Jay M., Fras, Zlatko, Goodman, Shaun G., Halvorsen, Sigrun, Hanotin, Corinne, Harrington, Robert A., Jukema, J. Wouter, Loizeau, Virginie, Moriarty, Patrick M., Moryusef, Angèle, Pordy, Robert, Roe, Matthew T., Sinnaeve, Peter, Tsimikas, Sotirios, Vogel, Robert, White, Harvey D., Zahger, Doron, Zeiher, Andreas M., Steg, Ph. Gabriel, Schwartz, Gregory G.

“…Lipoprotein(a) concentration is associated with cardiovascular events. Alirocumab, a proprotein convertase subtilisin/kexin type 9 inhibitor, lowers…”
Get full text

Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial by Jukema, J Wouter, Szarek, Michael, Zijlstra, Laurien E, de Silva, H Asita, Bhatt, Deepak L, Bittner, Vera A, Diaz, Rafael, Edelberg, Jay M, Goodman, Shaun G, Hanotin, Corinne, Harrington, Robert A, Karpov, Yuri, Moryusef, Angèle, Pordy, Robert, Prieto, Juan C, Roe, Matthew T, White, Harvey D, Zeiher, Andreas M, Schwartz, Gregory G, Steg, P Gabriel

“…Patients with acute coronary syndrome (ACS) and concomitant noncoronary atherosclerosis have a high risk of major adverse cardiovascular events (MACEs) and…”
Get full text

Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events: The ODYSSEY OUTCOMES Trial by Szarek, Michael, White, Harvey D, Schwartz, Gregory G, Alings, Marco, Bhatt, Deepak L, Bittner, Vera A, Chiang, Chern-En, Diaz, Rafael, Edelberg, Jay M, Goodman, Shaun G, Hanotin, Corinne, Harrington, Robert A, Jukema, J Wouter, Kimura, Takeshi, Kiss, Robert Gabor, Lecorps, Guillaume, Mahaffey, Kenneth W, Moryusef, Angèle, Pordy, Robert, Roe, Matthew T, Tricoci, Pierluigi, Xavier, Denis, Zeiher, Andreas M, Steg, Ph Gabriel

“…The ODYSSEY OUTCOMES (Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab) trial compared alirocumab with…”
Get full text

Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial by Harrington, Robert A, Pordy, Robert, Bhatt, Deepak L., Moryusef, Angèle, Sinnaeve, Peter, Pećin, Ivan, Novaretto, Leonardo P., Codutti, Oscar R., Vico, Marisa L., Bustamante Labarta, Miguel H, Arstall, Margaret A, Garrahy, Paul J, Wollaert, Bart, Kulić, Mehmed, Eliaschewitz, Freddy G, Kaiser, Sergio, Manenti, Euler Roberto Fernandes, Vuurmans, Tycho, Lai, Christopher, Olivares, Claudia, Chen, Jiyan, Huang, Weijian, Li, Xiang, Cheng, Xiaoshu, Wei, Meng, Fan, Zhongcai, Accini Mendoza, Jose L, Ghlonti, Ramaz, Schmidt, Ekkehard, Patsilinakos, Sotiris, Fausto Ovando, Sergio R, Yan, Bryan PY, Merkely, Bela, Premchand, Rajendra K, Kerkar, Prafulla, Patil, Sachin N, Chopda, Manoj, Chopra, Vijay K, Kumar, Vinay, Marco, Valgimigli, Cuccia, Claudio, Ferratini, Maurizio, Doi, Yasuji, Uematsu, Masaaki, Kim, Chongjin, Liew, Houng B, Llamas Esperón, Guillermo Antonio, Suarez Otero, Rodrigo, Kaplan, Refik, Gosselink, Antonius TM, Castillo Leon, Reynaldo P, Hernandez Zuniga, Jose D, Camacho Cosavalente, Luis A, Rodriguez Chavez, Víctor E, Wlodarczak, Adrian, Jaworska, Krystyna, Kubica, Jacek, Tesloianu, Dan N, Constantinescu, Mircea CA, Vishnevsky, Alexander Y, Povzun, Anton, Kanorsky, Sergey, Reuter, Helmuth, Cruz Fernández, Jose M, Worner Diz, Fernando, Bruguera Cortada, Jordi, Valdivielso, Pedro, Ponnamperuma, Chandrike, Huang, Tsuei-Yuan, Sukonthasarn, Apichard, Sansanayudh, Nakarin, Kehasukcharoen, Wirash, Ural, Ertan, Karpenko, Oleksandr, Mostovoy, Yuriy, Malynovsky, Yaroslav, Kopytsya, Mykola, Yagensky, Andriy, Griffiths, Huw, Kurian, John, Palmer, Bruce, White, Lindsey, Klancke, Kim, Waider, Winfried, Henderson, David, Mody, Freny, Park, Hyeun (Tom), Vidovich, Mladen, Rozeman, Phillip, Espinoza, Andrey, Pereira, Edward, Spriggs, Douglas, Nahhas, Ahed, Sharma, Mukesh, Bayron, Carlos, Gilmore, Richard, Ball, Eric, Mrabti, Asmaa, Kralova, Katarina, Etienne, Alexis

“…After acute coronary syndrome, diabetes conveys an excess risk of ischaemic cardiovascular events. A reduction in mean LDL cholesterol to 1·4–1·8 mmol/L with…”
Get full text

Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery by Goodman, Shaun G., Aylward, Philip E., Szarek, Michael, Chumburidze, Vakhtang, Bhatt, Deepak L., Bittner, Vera A., Diaz, Rafael, Edelberg, Jay M., Hanotin, Corinne, Harrington, Robert A., Jukema, J. Wouter, Kedev, Sasko, Letierce, Alexia, Moryusef, Angele, Pordy, Robert, Ramos López, Gabriel Arturo, Roe, Matthew T., Viigimaa, Margus, White, Harvey D., Zeiher, Andreas M., Steg, Ph. Gabriel, Schwartz, Gregory G.

“…Patients with acute coronary syndrome (ACS) and history of coronary artery bypass grafting (CABG) are at high risk for recurrent cardiovascular events and…”
Get full text

Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes by Roe, Matthew T., Li, Qian H., Bhatt, Deepak L., Bittner, Vera A., Diaz, Rafael, Goodman, Shaun G., Harrington, Robert A., Jukema, J. Wouter, Lopez-Jaramillo, Patricio, Lopes, Renato D., Louie, Michael J., Moriarty, Patrick M., Szarek, Michael, Vogel, Robert, White, Harvey D., Zeiher, Andreas M., Baccara-Dinet, Marie T., Steg, Ph Gabriel, Schwartz, Gregory G.

“…Background: The 2018 US cholesterol management guidelines recommend additional lipid-lowering therapies for secondary prevention in patients with low-density…”
Get full text

Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome by Schwartz, Gregory G., Steg, P. Gabriel, Szarek, Michael, Bhatt, Deepak L., Bittner, Vera A., Diaz, Rafael, Edelberg, Jay M., Goodman, Shaun G., Hanotin, Corinne, Harrington, Robert A., Jukema, J. Wouter, Lecorps, Guillaume, Mahaffey, Kenneth W., Moryusef, Angèle, Pordy, Robert, Quintero, Kirby, Roe, Matthew T., Sasiela, William J., Tamby, Jean-François, Tricoci, Pierluigi, White, Harvey D., Zeiher, Andreas M.

Get full text

Strain-rate insensitive yield strength and deformation mechanisms of Ni-base superalloy CM247LC at 600 °C by Zhang, P., Yuan, Y., Gao, Z.H., Gu, Y.F., Li, J., Yan, J.B., Gong, X.F., Lu, J.T., Shi, X.B., Fu, B.Q.

“…The compression deformation behavior and deformation mechanisms of [001]-oriented single crystal CM247LC are investigated at 600 °C and at the strain rate of…”
Get full text

Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large‐scale Chinese population by Zhang, HY, Zhu, FF, Xiong, J, Shi, XB, Fu, SX

“…Objective  To analyse the phenotypic spectrum of polycystic ovary syndrome (PCOS) and determine the association between metabolic, hormonal and new…”
Get full text

Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial by Szarek, Michael, Steg, Ph. Gabriel, DiCenso, Dina, Bhatt, Deepak L., Bittner, Vera A., Budaj, Andrzej, Diaz, Rafael, Goodman, Shaun G., Gotcheva, Nina, Jukema, J. Wouter, Pordy, Robert, Roe, Matthew T., Sourdille, Timothée, White, Harvey D., Xavier, Denis, Zeiher, Andreas M., Schwartz, Gregory G.

“…Background: In ODYSSEY OUTCOMES (Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab), alirocumab was…”
Get full text

The fellowships of the INGs by Shi, Xiaobing, Gozani, Or

“…The inhibitor of growth (ING) family of proteins is an evolutionarily conserved family, with members present from yeast to humans. The mammalian ING proteins…”
Get full text

Fluorescent-Conjugated Polymer Superquenching Facilitates Highly Sensitive Detection of Proteases by Kumaraswamy, Sriram, Bergstedt, Troy, Shi, Xiaobo, Rininsland, Frauke, Kushon, Stuart, Xia, Wensheng, Ley, Kevin, Achyuthan, Komandoor, McBranch, Duncan, Whitten, David, Meyer, Thomas J.

“…Sensor formats have been developed for detecting the activity of proteolytic enzymes based on fluorescent conjugated polymer superquenching. These sensors…”
Get full text

Metal Ion-Mediated Polymer Superquenching for Highly Sensitive Detection of Kinase and Phosphatase Activities by Rininsland, Frauke, Xia, Wensheng, Wittenburg, Shannon, Shi, Xiaobo, Stankewicz, Casey, Achyuthan, Komandoor, McBranch, Duncan, Whitten, David, Heeger, Alan J.

“…An assay technology for high-throughput screening of kinase and phosphatase activities is introduced. The format is based upon superquenching of…”
Get full text

Inorganic Polyphosphate in Bacillus cereus: Motility, Biofilm Formation, and Sporulation by Shi, Xiaobing, Rao, Narayana N., Kornberg, Arthur

“…Chains of inorganic polyphosphate (poly-P) with hundreds of P i residues linked by phosphoanhydride bonds, as in ATP, are found in every bacterial, fungal,…”
Get full text

Endopolyphosphatase in Saccharomyces cerevisiae undergoes post-translational activations to produce short-chain polyphosphates by Shi, Xiaobing, Kornberg, Arthur

“…Endopolyphosphatase (Ppn), responsible for cleavage of long chain inorganic polyphosphate (poly P) of several hundred residues to generate progressively…”
Get full text

Characteristics of surface heat flow in the South China Sea by Shi, Xiaobin, Qiu, Xuelin, Xia, Kanyuan, Zhou, Di

“…A total of 592 heat flow measurements, ranging from 8 to 192 mW/m 2, 78 percent of which are between 50 and 100 mW/m 2, have been collected in the South China…”
Get full text

Crustal structure across the Xisha Trough, northwestern South China Sea by Qiu, Xuelin, Ye, Sanyu, Wu, Shimin, Shi, Xiaobin, Zhou, Di, Xia, Kanyuan, Flueh, Ernst R.

“…Located at the northwestern part of the South China Sea (SCS) between the Hainan and Xisha (Paracel) Islands, the Xisha Trough represents a failed rift in…”
Get full text

Intrusion and its implication for subsidence: A case from the Baiyun Sag, on the northern margin of the South China Sea by Shi, Xiaobin, Burov, Evgenii, Leroy, Sylvie, Qiu, Xuelin, Xia, Bin

“…We develop a series of simple numerical models to explain the anomalous subsidence and deposition phenomena on the northern continental margin of the South…”
Get full text

Functional analysis of 44 mutant androgen receptors from human prostate cancer by SHI, Xu-Bao, MA, Ai-Hong, LIANG XIA, KUNG, Hsing-Jien, DE VERE WHITE, Ralph W

“…Mutations of the androgen receptor gene are believed to contribute to the androgen-independent growth of prostate cancer cells. To date, 56 missense mutations…”
Get full text

Protein kinase p-JNK is correlated with the activation of AP-1 and its associated Jun family proteins in hepatocellular carcinoma by Guo, Linlang, Guo, Ying, Xiao, Sha, Shi, Xiaobao

“…To study the role of c-Jun N-terminal kinase (JNK) and its relation to transcription factor AP-1 and Jun family proteins in hepatocellular carcinoma (HCC) with…”
Get full text